Lv4
440 积分 2025-10-14 加入
Outcome of tocilizumab treatment in corticosteroid-resistant thyroid eye disease
2天前
已完结
Tocilizumab for the Management of Thyroid-Associated Orbitopathy
2天前
已完结
Efficacy and safety of Tocilizumab for thyroid eye disease: a systemic review and Meta-analysis
2天前
已完结
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management
5天前
已完结
Systemic Effects of Teprotumumab Treatment on Thyroid Function in Patients With Thyroid Eye Disease: A Retrospective Study
5天前
已关闭
Extended Long-Term Follow-Up of Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease
5天前
已关闭
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
26天前
已完结
Efficacy and safety of Tocilizumab for thyroid eye disease: a systemic review and Meta-analysis
27天前
已完结
Relationship between Serum Thyroid-stimulating Hormone Receptor Autoantibodies and Activity and Severity of Thyroid Eye Disease
1个月前
已完结
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management
1个月前
已完结
皖公网安备34019202002308
